Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Vieyra-Garcia, PA; Wei, T; Naym, DG; Fredholm, S; Fink-Puches, R; Cerroni, L; Odum, N; O'Malley, JT; Gniadecki, R; Wolf, P.
STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Clin Cancer Res. 2016; 22(13):3328-3339 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Cerroni Lorenzo
Fink-Puches Regina
Vieyra Garcia Pablo Augusto
Wolf Peter

Dimensions Citations:

Plum Analytics:
Number of Figures: 6
| | | | | |
Sustained inflammation is a key feature of mycosis fungoides (MF), the most common form of cutaneous T-cell lymphoma (CTCL). Resident IL9-producing T cells have been found in skin infections and certain inflammatory skin diseases, but their role in MF is currently unknown. We analyzed lesional skin from patients with MF for the expression of IL9 and its regulators. To determine which cells were producing IL9, high-throughput sequencing was used to identify malignant clones and Vb-specific antibodies were employed to visualize malignant cells in histologic preparations. To explore the mechanism of IL9 secretion, we knocked down STAT3/5 and IRF4 by siRNA transfection in CTCL cell lines receiving psoralen+UVA (PUVA) ± anti-IL9 antibody. To further examine the role of IL9 in tumor development, the EL-4 T-cell lymphoma model was used in C57BL/6 mice. Malignant and reactive T cells produce IL9 in lesional skin. Expression of the Th9 transcription factor IRF4 in malignant cells was heterogeneous, whereas reactive T cells expressed it uniformly. PUVA or UVB phototherapy diminished the frequencies of IL9- and IL9r-positive cells, as well as STAT3/5a and IRF4 expression in lesional skin. IL9 production was regulated by STAT3/5 and silencing of STAT5 or blockade of IL9 with neutralizing antibodies potentiated cell death after PUVA treatment in vitro IL9-depleted mice exhibited a reduction of tumor growth, higher frequencies of regulatory T cells, and activated CD4 and CD8 T lymphocytes. Our results suggest that IL9 and its regulators are promising new targets for therapy development in mycosis fungoides. Clin Cancer Res; 22(13); 3328-39. ©2016 AACR. ©2016 American Association for Cancer Research.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aged, 80 and over -
Animals -
CD8-Positive T-Lymphocytes - immunology
Cell Line, Tumor -
Cell Proliferation -
Cell Survival -
Female -
High-Throughput Nucleotide Sequencing -
Humans -
Interferon Regulatory Factors - genetics
Interferon Regulatory Factors - metabolism
Interleukin-9 - biosynthesis
Lymphocyte Activation - immunology
Lymphocyte Count -
Male -
Mice -
Mice, Inbred C57BL -
Middle Aged -
Mycosis Fungoides - pathology
RNA Interference -
RNA, Small Interfering - genetics
STAT3 Transcription Factor - genetics
STAT3 Transcription Factor - metabolism
STAT5 Transcription Factor - genetics
STAT5 Transcription Factor - metabolism
T-Lymphocytes, Regulatory - immunology
Tumor Suppressor Proteins - genetics
Tumor Suppressor Proteins - metabolism

© Meduni Graz Impressum